The trademark application DELMINPRI was filed by CymaBay Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 14, 2022, and it was registered by office on September 21, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on June 2, 2024.